Psilocybin molecule:

Image from PubChem

Psilocybin Clinical Trials


Psilocybin - Induced Neuroplasticity in the Treatment of Major Depressive Disorder


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT03554174

Organisation Name: Yale University

Overal Status: Recruiting

Start Date: June 30, 2018

Last Update: January 8, 2021

Lead Sponsor: Yale University

Brief Summary: The primary goal of this pilot study is to investigate whether psilocybin alters neuroplasticity in people with major depressive disorder. The primary hypothesis is that psilocybin will result in neuroplastic changes that parallel improvement in symptoms of depression.

Conditions:
  • Major Depressive Disorder


Total execution time in seconds: 0.18156599998474